Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neumega in Type 1 Von Willebrand Disease
NCT00151125Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Jul 2004
- Primary completion
- Dec 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of oprelvekin in Von Willebrand disease type 1, sponsored by University of Pittsburgh. Started Jul 2004; status: completed.
02
Drugs
oprelvekin
03
Conditions
Von Willebrand disease type 1
Beyond the preview
Go deeper on NCT00151125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151125.